M E Brandt

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. pmc Utility of random amplified polymorphic DNA PCR and TaqMan automated detection in molecular identification of Aspergillus fumigatus
    M E Brandt
    Division of Bacterial and Mycotic Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Clin Microbiol 36:2057-62. 1998
  2. pmc Atypical Aspergillus flavus isolates associated with chronic azole therapy
    Mary E Brandt
    Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Clin Microbiol 47:3372-5. 2009
  3. pmc False-positive Histoplasma capsulatum Gen-Probe chemiluminescent test result caused by a Chrysosporium species
    Mary E Brandt
    Mycotic Diseases Branch, Centers for Disease Control and Prevention, 1600 Clifton Road, Mail stop G 11, Atlanta, GA 30333, USA
    J Clin Microbiol 43:1456-8. 2005
  4. pmc Fungemia caused by Zygoascus hellenicus in an allogeneic stem cell transplant recipient
    Mary E Brandt
    Mycotic Diseases Branch, Division of Bacterial and Mycotic Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd, Mailstop G 11, Atlanta, GA 30333, USA
    J Clin Microbiol 42:3363-5. 2004
  5. ncbi request reprint Pseudooutbreak of Candida versatilitis fungemia in a microbiology laboratory
    Mary E Brandt
    Mycotic Diseases Branch, Division of Bacterial and Mycotic Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Diagn Microbiol Infect Dis 46:73-5. 2003
  6. pmc Candida dubliniensis fungemia: the first four cases in North America
    M E Brandt
    Centers for Disease Control and Prevention CDC Atlanta, Georgia, USA
    Emerg Infect Dis 6:46-9. 2000
  7. pmc Molecular subtype distribution of Cryptococcus neoformans in four areas of the United States. Cryptococcal Disease Active Surveillance Group
    M E Brandt
    Emerging Bacterial and Mycotic Diseases Branch, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Clin Microbiol 34:912-7. 1996
  8. ncbi request reprint Candidemia in pediatric outpatients receiving home total parenteral nutrition
    M V Cano
    Division of Bacterial and Mycotic Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Med Mycol 43:219-25. 2005
  9. ncbi request reprint Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. Cryptococcal Active Surveillance Group
    R A Hajjeh
    Centers for Disease Control and Prevention, Mycotic Diseases Branch, Division of Bacterial and Mycotic Diseases, Atlanta, GA 30333, USA
    J Infect Dis 179:449-54. 1999
  10. pmc Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates in the United States: 1992 to 1994 and 1996 to 1998
    M E Brandt
    Mycotic Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Antimicrob Agents Chemother 45:3065-9. 2001

Collaborators

Detail Information

Publications15

  1. pmc Utility of random amplified polymorphic DNA PCR and TaqMan automated detection in molecular identification of Aspergillus fumigatus
    M E Brandt
    Division of Bacterial and Mycotic Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Clin Microbiol 36:2057-62. 1998
    ..This RAPD-PCR and TaqMan assay offers promise as a nucleic acid-based system that can be used for the identification of filamentous fungal isolates and that requires no postamplification sample manipulations...
  2. pmc Atypical Aspergillus flavus isolates associated with chronic azole therapy
    Mary E Brandt
    Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Clin Microbiol 47:3372-5. 2009
    ..We speculate that this lengthy exposure to azole antifungal drugs may have caused or promoted the atypical morphology seen in these isolates...
  3. pmc False-positive Histoplasma capsulatum Gen-Probe chemiluminescent test result caused by a Chrysosporium species
    Mary E Brandt
    Mycotic Diseases Branch, Centers for Disease Control and Prevention, 1600 Clifton Road, Mail stop G 11, Atlanta, GA 30333, USA
    J Clin Microbiol 43:1456-8. 2005
    ..capsulatum. The isolate was later identified as the Chrysosporium anamorph of Nannizziopsis vriesii by sequence analysis and phenotypic data...
  4. pmc Fungemia caused by Zygoascus hellenicus in an allogeneic stem cell transplant recipient
    Mary E Brandt
    Mycotic Diseases Branch, Division of Bacterial and Mycotic Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd, Mailstop G 11, Atlanta, GA 30333, USA
    J Clin Microbiol 42:3363-5. 2004
    ..The organism was misidentified by a commercial yeast identification system. This is the first reported case of human infection with this rare ascomycetous yeast...
  5. ncbi request reprint Pseudooutbreak of Candida versatilitis fungemia in a microbiology laboratory
    Mary E Brandt
    Mycotic Diseases Branch, Division of Bacterial and Mycotic Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Diagn Microbiol Infect Dis 46:73-5. 2003
    ..This unusual non-pathogenic yeast isolate was readily identified by DNA sequencing methodology. This report also points out that care must be taken to ensure the sterility of supplements added to blood culture media...
  6. pmc Candida dubliniensis fungemia: the first four cases in North America
    M E Brandt
    Centers for Disease Control and Prevention CDC Atlanta, Georgia, USA
    Emerg Infect Dis 6:46-9. 2000
    ..All isolates were susceptible in vitro to commonly used antifungal drugs. This report demonstrates that C. dubliniensis can cause bloodstream infection; however, the incidence of disease is not known...
  7. pmc Molecular subtype distribution of Cryptococcus neoformans in four areas of the United States. Cryptococcal Disease Active Surveillance Group
    M E Brandt
    Emerging Bacterial and Mycotic Diseases Branch, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Clin Microbiol 34:912-7. 1996
    ..neoformans possesses a clonal population structure. Continued application of molecular subtyping methods will be useful in tracking the source, transmission, and relative virulence of different C. neoformans strains...
  8. ncbi request reprint Candidemia in pediatric outpatients receiving home total parenteral nutrition
    M V Cano
    Division of Bacterial and Mycotic Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Med Mycol 43:219-25. 2005
    ..Our findings underscore the challenges of maintaining stringent infection control practices in the home health care setting and suggest the need for more intensive follow-up and coordination of home TPN therapy among pediatric patients...
  9. ncbi request reprint Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. Cryptococcal Active Surveillance Group
    R A Hajjeh
    Centers for Disease Control and Prevention, Mycotic Diseases Branch, Division of Bacterial and Mycotic Diseases, Atlanta, GA 30333, USA
    J Infect Dis 179:449-54. 1999
    ..Further studies are needed to better describe persons with AIDS currently developing cryptococcosis in the era of highly active antiretroviral therapy...
  10. pmc Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates in the United States: 1992 to 1994 and 1996 to 1998
    M E Brandt
    Mycotic Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Antimicrob Agents Chemother 45:3065-9. 2001
    ..We conclude that in vitro resistance to antifungal agents remains uncommon in C. neoformans and has not significantly changed with time during the past decade...
  11. pmc Improving molecular detection of fungal DNA in formalin-fixed paraffin-embedded tissues: comparison of five tissue DNA extraction methods using panfungal PCR
    C Muñoz-Cadavid
    Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    J Clin Microbiol 48:2147-53. 2010
    ..Factors such as sensitivity, cost, and labor will help guide the selection of the most appropriate method for the needs of each laboratory...
  12. ncbi request reprint Epidemiology, clinical manifestations, and therapy of infections caused by dematiaceous fungi
    M E Brandt
    Mycotic Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Chemother 15:36-47. 2003
    ..The development of new antifungal agents and combination treatment may help to improve the management of these infections...
  13. pmc Posaconazole treatment for Apophysomyces elegans rhino-orbital zygomycosis following trauma for a male with well-controlled diabetes
    T D Ferguson
    Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA
    J Clin Microbiol 45:1648-51. 2007
    ..The causative agent was identified as Apophysomyces elegans, an emerging cause of zygomycosis in immunocompetent hosts...
  14. ncbi request reprint Population-based surveillance and a case-control study of risk factors for endemic lymphocutaneous sporotrichosis in Peru
    G M Lyon
    Epidemic Intelligence Service, Epidemiology Program Office, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Clin Infect Dis 36:34-9. 2003
    ..Decreased environmental exposure, such wearing protective clothing during construction activities for adults or limiting contact with cats and soil for children, and improvements in living spaces may decrease the incidence of LS...